Molbio Diagnosti

  • Market Cap: N/A
  • Industry: Healthcare Services
  • ISIN: INE869T01028
  • NSEID:
  • BSEID: 544866
INR
1,449.50
-29.85 (-2.02%)
BSENSE

Oct 09

BSE+NSE Vol: 63081

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

63.08 k (-85.22%) Volume

Shareholding (Aug 2026)

FII

0.00%

Held by 0 FIIs

DII

52.21%

Held by 6 DIIs

Promoter

41.29%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 16,704 Cr ()

stock-summary
P/E

116.00

stock-summary
Industry P/E

60

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

15.02

Revenue and Profits:
Net Sales:
408 Cr
(Quarterly Results - Jun 2026)
Net Profit:
59 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

01-Oct-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for India Business Excellence Fund III

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

01-Oct-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for India Business Excellence Fund III

Closure of Trading Window

28-Sep-2026 | Source : BSE

Intimation of Closure of Trading Window for the Quarter ended September 302026.

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
18.50
Debt to EBITDA (avg)
0.88
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.92
Tax Ratio
26.79%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
52.21%
ROCE (avg)
21.92%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
116
Industry P/E
60
Price to Book Value
15.02
EV to EBIT
79.92
EV to EBITDA
68.58
EV to Capital Employed
12.70
EV to Sales
13.15
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.89%
ROE (Latest)
12.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
No Trend
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Aug 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Exxora Trading Llp (37.05%)

Highest Public shareholder

Business Excellence Trust Iii - India Business Exc (11.52%)

Individual Investors Holdings

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -8.96% vs 360.25% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -13.79% vs 589.86% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "399.38",
          "val2": "438.71",
          "chgp": "-8.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "91.64",
          "val2": "107.04",
          "chgp": "-14.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "8.66",
          "val2": "9.28",
          "chgp": "-6.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "56.63",
          "val2": "65.69",
          "chgp": "-13.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.95%",
          "val2": "24.40%",
          "chgp": "-1.45%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Molbio Diagnosti"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Molbio Diagnosti"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 35.23% vs 28.42% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 3.44% vs 25.84% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,313.40",
          "val2": "971.23",
          "chgp": "35.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "251.86",
          "val2": "225.63",
          "chgp": "11.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.15",
          "val2": "8.86",
          "chgp": "161.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.13",
          "val2": "-8.80",
          "chgp": "64.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "144.63",
          "val2": "139.82",
          "chgp": "3.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.18%",
          "val2": "23.23%",
          "chgp": "-4.05%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQstock-summary
Jun'26
Mar'26
Change(%)
Net Sales
399.38
438.71
-8.96%
Operating Profit (PBDIT) excl Other Income
91.64
107.04
-14.39%
Interest
8.66
9.28
-6.68%
Exceptional Items
0.00
0.00
Standalone Net Profit
56.63
65.69
-13.79%
Operating Profit Margin (Excl OI)
22.95%
24.40%
-1.45%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is -8.96% vs 360.25% in Mar 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is -13.79% vs 589.86% in Mar 2026

Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
1,313.40
971.23
35.23%
Operating Profit (PBDIT) excl Other Income
251.86
225.63
11.63%
Interest
23.15
8.86
161.29%
Exceptional Items
-3.13
-8.80
64.43%
Standalone Net Profit
144.63
139.82
3.44%
Operating Profit Margin (Excl OI)
19.18%
23.23%
-4.05%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 35.23% vs 28.42% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 3.44% vs 25.84% in Mar 2025

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details